We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




IVD Sector in India Shows Stable Growth and Exhibits Potential

By LabMedica International staff writers
Posted on 31 Jan 2016
Print article
According to a new report, the in vitro diagnostic (IVD) testing sector in India is estimated to have reached USB 782 million in 2015 and modernizing healthcare infrastructure and steady migration from manual to automated processes will support additional growth.

The report “IVD in India” by Kalorama Information (New York, NY, USA) places India and its IVD market in context with the developing world in terms of diseases, economic and healthcare system development, and other key metrics related to health expenditures and diagnostics.

“India will continue to offer one of the better markets for IVD products among emerging nations because of its economic stability,” said Bruce Carlson, publisher of Kalorama Information. “Leading IVD companies have all established themselves in India and are seeking long-term market growth in the country.”

India has the world’s 7th-largest economy by nominal gross domestic product (GDP), 3rd largest by purchasing power parity, and a stable growth rate averaging approximately 7% for the last 2 decades. Its long-term growth prospects are considered moderate due to its young population, corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy.

India as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise—Brazil, Russia, China. India and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, obesity and diseases of aging. Economic growth has been fueled largely by the transfer of know-how, technology, and business practices from developed countries, as Indian citizens educated and working outside of the country return or send resources to friends and family at home.

Product opportunities for international IVD companies include rugged, easy-to-use rapid tests with built-in high specificity and sensitivity for applications in rural healthcare. Opportunities also exist for instrumentation in advanced diagnostics, including sequencers and molecular test analyzers, as well as microarrays and other multianalyte assays and multi-tool analyzers capable of running hematology and immunodiagnostic assays.

Kalorama’s new report features a 10-year forecast period, with projections of the total Indian IVD market and its component segments from 2015-2025; as well as IVD sales by segment (immunoassays, clinical chemistry, hematology, POC/OTC, molecular, urinalysis, other) in 2015, in 2020, and in 2025.

Related Links:

Kalorama Information
IVD in India, report


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Cancer Mutation Profiling Liquid Kit
OncoScreen Plus

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.